In the wake of a recall of Zantac by the United States Food and Drug Administration (FDA), patients from across the country have associated their use of the medication with cancer diagnoses.
Zantac includes the substance ranitidine, which is found in many other heartburn treatment drugs. N-Nitrosodimethylamine (NDMA), a known carcinogenic substance, has been detected in multiple ranitidine-based medications. NDMA may be the cause of Zantac-associated cancer diagnoses. Many of these cases involve the development of colon cancer in regular Zantac users.
Colon cancer can be detected through preventative testing methods, such as colonoscopies. Older adults and others who are at risk for colon cancer development may complete regular colonoscopy tests. Without testing, colon cancer can be identified by common symptoms. Colon cancer is generally marked by pain and discomfort, changes in bowel habits, and changes in the appearance of stool.
Contact your doctor if you are a regular Zantac user and have identified any of these common signs of colon cancer:
- Abdominal pain and discomfort
- Weight loss
- Blood in stool
- Changes in stool appearance and/or consistency
- Changes in bowel habits
- Weakness and fatigue
As an orally administered drug, the use of Zantac may contribute to cancers of the digestive system, including colon cancer. The presence of NDMA in Zantac, and the cancer-causing interactions of ranitidine within the body, are evidence of manufacturer negligence.
Regular Zantac users who have developed colon cancer may be entitled to compensation for medical bills, lost wages, and non-economic damages such as pain and suffering.
Our legal team is prepared to evaluate your case to determine who is liable for your cancer diagnosis, quantify your damages, and recover the compensation you deserve. Contact us to discuss the details of your case.
Send us a message or call (216) 600-0114 to schedule a free consultation with our lawyers.